| pubmed-article:17300636 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17300636 | lifeskim:mentions | umls-concept:C0023290 | lld:lifeskim |
| pubmed-article:17300636 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:17300636 | lifeskim:mentions | umls-concept:C0680804 | lld:lifeskim |
| pubmed-article:17300636 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:17300636 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17300636 | pubmed:dateCreated | 2007-2-15 | lld:pubmed |
| pubmed-article:17300636 | pubmed:abstractText | To facilitate the choice of the best visceral leishmaniasis (VL) treatment strategy for first-line health services in (VL)-endemic areas, we compared in a formal decision analysis the cost and the cost-effectiveness of the different available options. | lld:pubmed |
| pubmed-article:17300636 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17300636 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17300636 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17300636 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17300636 | pubmed:issn | 1360-2276 | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:DiazMM | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:BoelaertMM | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:GuerinP JPJ | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:GerstlSS | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:VanlerbergheV... | lld:pubmed |
| pubmed-article:17300636 | pubmed:author | pubmed-author:MeheusFF | lld:pubmed |
| pubmed-article:17300636 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17300636 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:17300636 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17300636 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17300636 | pubmed:pagination | 274-83 | lld:pubmed |
| pubmed-article:17300636 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:meshHeading | pubmed-meshheading:17300636... | lld:pubmed |
| pubmed-article:17300636 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17300636 | pubmed:articleTitle | Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. | lld:pubmed |
| pubmed-article:17300636 | pubmed:affiliation | Epidemiology and Disease Control Unit, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium. vvanlerberghe@itg.be | lld:pubmed |
| pubmed-article:17300636 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17300636 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17300636 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17300636 | lld:pubmed |
